Embria Expands Market Reach For EpiCor Through Local Government
This article was originally published in The Tan Sheet
Executive Summary
Embria Health Sciences is providing its "immune balancing" branded ingredient EpiCor below retail price to employees of its Iowa hometown during the cold and flu season in a strategic move to generate consumer brand recognition and manufacturer demand.
You may also be interested in...
Embria Studies FDA Expectations Before Successful EpiCor NDI
FDA’s formal acknowledgment of Embria’s NDI notification for EpiCor comes after the firm called FDA early in the process to discuss the pending notification and worked to understand the agency’s expectations fully. Kevin Boot, Embria’s regulatory counsel, recommends simple notifications that are “readable by everyone.”
Embria Studies FDA Expectations Before Successful EpiCor NDI
FDA’s formal acknowledgment of Embria’s NDI notification for EpiCor comes after the firm called FDA early in the process to discuss the pending notification and worked to understand the agency’s expectations fully. Kevin Boot, Embria’s regulatory counsel, recommends simple notifications that are “readable by everyone.”
In Brief
Dr. Reddy’s launches Allegra-D equivalent